[Federal Register Volume 79, Number 49 (Thursday, March 13, 2014)]
[Notices]
[Page 14298]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-05505]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Morton Grove Pharmaceuticals

    By Notice dated November 5, 2013, and published in the Federal 
Register on November 18, 2013, 78 FR 69133, Morton Grove 
Pharmaceuticals, 6451 Main Street, Morton Grove, Illinois 60053-2633, 
made application by renewal to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of Gamma Hydroxybutyric 
Acid (2010), a basic class of controlled substance listed in schedule 
I.
    The company plans to manufacture a controlled substance for product 
development.
    No comments or objections have been received. The DEA has 
considered the factors in 21 U.S.C. 823(a), and determined that the 
registration of Morton Grove Pharmaceuticals to manufacture the listed 
basic class of controlled substance is consistent with the public 
interest at this time. The DEA has investigated Morton Grove 
Pharmaceuticals to ensure that the company's registration is consistent 
with the public interest. The investigation has included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 
823(a) and in accordance with 21 CFR 1301.33, the above named company 
is granted registration as a bulk manufacturer of the basic class of 
controlled substance listed.

    Dated: February 19, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2014-05505 Filed 3-12-14; 8:45 am]
BILLING CODE 4410-09-P